ANRO
Alto Neuroscience, Inc.NYSEHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$744.69M
P/E Ratio
—
EPS
$-2.43
Beta
1.65
52W High
$28.44
52W Low
$2.15
50-Day MA
$23.36
200-Day MA
$14.82
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Alto Neuroscience, Inc.
Alto Neuroscience, Inc. is a clinical-stage biopharmaceutical company that engages in the psychiatry drug development business. The company is headquartered in Los Altos, California.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-77.15M |
| Operating Margin | 0.00% |
| Return on Equity | -38.90% |
| Return on Assets | -21.70% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $6.94 |
| Price-to-Book | 3.06 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $35.09M |
| Float | $23.95M |
| % Insiders | 4.55% |
| % Institutions | 76.86% |
Historical Volatility
HV 10-Day
63.30%
HV 20-Day
52.90%
HV 30-Day
69.04%
HV 60-Day
74.64%
HV Rank
—
Volatility is currently contracting
Analyst Ratings
Consensus ($35.13 target)
9
Buy1
HoldMore HEALTHCARE Stocks
Data last updated: 5/25/2026